The objective of the Administration, Mentoring and Recruitment Core is to assist all of the COBRE team members by providing administrative service. In the first Phase of the COBRE, the Core has been responsible for budgeting, ordering, progress report submission for the entire COBRE, and organizing meetings of the External Advisory Committee and the Internal Advisory Committee as well as meetings of COBRE Promising Junior Investigators (PJIs). This Core has substantially reduced the workload of PJIs in their administrative work and enhanced collaborations between PJIs, thus contributing to the overall success of our COBRE. This Core will be responsible for the overall administration of the COBRE including: announcement of openings of COBRE PJI or Early Career Investigator (ECl) positions and pilot projects, selecting PJIs/ECIs and mentors based on the EAC's recommendations, establishing the mentoring program, overseeing the overall budget, organizing meetings of the EAC and lAC, organizing the seminar series, interacting with all the Core directors and PJIs, following the progress and milestones of PJI's projects, and submitting progress reports to NCRR. The Core will also work closely with the Harold Hamm Diabetes Center and the Provost the Oklahoma University Health Sciences Center and the Dean of the College of Medicine to recruit new investigators to Oklahoma. Finally, the Administration Core will continue to organize the Annual Diabetes Research Symposium to enhance collaboration.

Public Health Relevance

Diabetes represents a major threat to the health of working age populations. More diabetes research is required to understand the pathogenesis of diabetes and its complications and develop new treatments. This Core is to provide administrative support to diabetes researchers and enhance collaborations between basic scientists and clinicians in diabetes research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM104934-08
Application #
8692931
Study Section
Special Emphasis Panel (ZRR1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
8
Fiscal Year
2014
Total Cost
Indirect Cost
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Wang, Bing; Li, Pui-Kai; Ma, Jian-Xing et al. (2018) Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage. Invest Ophthalmol Vis Sci 59:3630-3642
Shin, Younghwa; Moiseyev, Gennadiy; Petrukhin, Konstantin et al. (2018) A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochim Biophys Acta Mol Basis Dis 1864:2420-2429
Fu, Shuhua; Dong, Shuqian; Zhu, Meili et al. (2018) VEGF as a Trophic Factor for Müller Glia in Hypoxic Retinal Diseases. Adv Exp Med Biol 1074:473-478
Orock, Albert; Logan, Sreemathi; Deak, Ferenc (2018) Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome. Mol Cell Neurosci 88:33-42
Chen, Qian; Qiu, Fangfang; Zhou, Kelu et al. (2017) Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPAR?. Diabetes 66:1671-1682
Du, Mei; Martin, Ashley; Hays, Franklin et al. (2017) Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol Vis 23:185-197
Malechka, Volha V; Moiseyev, Gennadiy; Takahashi, Yusuke et al. (2017) Impaired Rhodopsin Generation in the Rat Model of Diabetic Retinopathy. Am J Pathol 187:2222-2231
Qiu, Fangfang; Liu, Zhen; Zhou, Yueping et al. (2017) Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration. Sci Rep 7:1263
Pearsall, Elizabeth A; Cheng, Rui; Zhou, Kelu et al. (2017) PPAR? is essential for retinal lipid metabolism and neuronal survival. BMC Biol 15:113
Le, Yun-Zheng (2017) VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 139:108-114

Showing the most recent 10 out of 101 publications